Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sonoma Pharmaceuticals, Inc. - Common Stock
(NQ:
SNOA
)
2.020
-0.090 (-4.27%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sonoma Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Unusual volume stocks are being observed in Tuesday's session.
March 11, 2025
In today's session, these stocks are experiencing unusual volume.
Via
Chartmill
What's Going On With Sonoma Pharmaceuticals Stock Tuesday?
March 11, 2025
Sonoma stock is trading higher on Tuesday after the company announced that it secured U.K. regulatory clearance for its key wound care and dermatology products.
Via
Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
March 11, 2025
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via
Chartmill
Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
March 11, 2025
Via
Benzinga
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results
February 05, 2025
Via
ACCESS Newswire
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results
November 07, 2024
Via
ACCESSWIRE
What's going on in today's after hours session
March 10, 2025
After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via
Chartmill
Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)
March 10, 2025
Via
ACCESS Newswire
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket
March 10, 2025
Via
Benzinga
Why Sonoma Pharmaceuticals (SNOA) Stock Is Moving
August 28, 2024
Sonoma Pharmaceuticals shares are trading lower by 7.8% Wednesday morning. The company announced a 1-for-20 reverse stock split.
Via
Benzinga
Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results
August 08, 2024
Via
ACCESSWIRE
Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando
February 25, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 06, 2024
Via
Benzinga
Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices
December 05, 2024
Via
ACCESSWIRE
Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States
November 21, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 19, 2024
Via
Benzinga
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel
November 11, 2024
Via
ACCESSWIRE
Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf
October 31, 2024
Via
ACCESSWIRE
Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada
October 22, 2024
Via
ACCESSWIRE
Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences
October 21, 2024
Via
ACCESSWIRE
Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
September 19, 2024
Via
ACCESSWIRE
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution
September 17, 2024
Via
ACCESSWIRE
Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line
September 11, 2024
Via
ACCESSWIRE
Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock
August 28, 2024
Via
ACCESSWIRE
Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff
August 26, 2024
Via
ACCESSWIRE
Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States
August 21, 2024
Via
ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
August 12, 2024
It's time to dive into the biggest pre-market stock movers for Monday morning with all of the latest news affecting shares today!
Via
InvestorPlace
Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket
August 12, 2024
Via
Benzinga
SNOA Stock Earnings: Sonoma Pharmaceuticals Misses EPS, Misses Revenue for Q1 2025
August 09, 2024
SNOA stock results show that Sonoma Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2025.
Via
InvestorPlace
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 22, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.